Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,592.53
(
-0.49%
)
US TECH 100
23,604.40
(
-0.81%
)
Dow Jones
45,931.56
(
-0.64%
)
Brent Oil
104.17
(
-2.27%
)
Bitcoin
69,908.23
(
-1.87%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 209826

Sunday, 05/14/2017 6:28:08 PM

Sunday, May 14, 2017 6:28:08 PM

Post# of 257259
MNTA ‘ReadMeFirst’ updated:

2017-2018 news flow;
reasons to be optimistic;
1Q17 financial results, liquidity, and diluted share count;
transcript of 1Q17 CC;
phase-3 trial of M923 meets FDA draft guidelines for interchange FoBs;
incoming FDA commissioner (Scott Gottlieb) emphasizes interchangeable FoBs;
an interchangeable Humira FoB for US market is badly needed (chart).

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131348030

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now